Open research questions in Bone health and treatments
29 unresolved questions extracted from the limitations and future-work sections of 758 Bone health and treatments papers in our library. Each links back to the study that raised it.
What the literature leaves open
Although BP-induced oral health problems are increasingly receiving attention, quantitative data validating the impact of such medication on alveolar bone conditions are scarce.
Elevated alveolar bone mineral density in female patients undergoing bisphosphonate therapy: A pilot cross‐sectional study using intraoral radiographs · 2024 · DOIAlthough the relationship between mandibular osteonecrosis and rheumatoid arthritis is not completely understood, we can conclude that the dental surgeon and the rheumatologist must always be in communication in order to treat mandibular osteonecrosis in the best possible way, as well as prevent its onset.
Denture trauma has been reported to be a risk factor for MRONJ, and few reports have discussed the prosthodontic considerations needed for patients with this condition.
OBJECTIVES: While risk factors of bisphosphonate (BP) associated osteonecrosis of the jaw have been properly analyzed, studies focusing on risk factors associated with denosumab (DNO) are sparse.
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab · 2021 · DOIThe pathogenesis of denosumab-induced ONJ is not clearly defined, but it seems that the success rate in healing after drug discontinuation is higher than in bisphosphonates-induced ONJ.
Osteonecrosis de los maxilares asociada a denosumab en una paciente con osteoporosis: un caso clínico · 2014 · DOIAttention to be given to this bone pathologies in children and adolescents is warranted of its prognostic value for the rest of his life, to the peak bone mass of 20-21 years of age.
Studies on the relationship between bone tissue osteoporosis and the development of chronic generalized periodontitis are known in medicine; however, data on bone tissue changes in young patients with rapidly progressive periodontitis are insufficient.
CHANGES IN THE BLOOD CHEMISTRY VALUES IN THE COURSE OF THE TREATMENT OF THE RAPIDLY PROGRESSIVE PERIODONTITIS · 2026 · DOITheir patho-physiology still presents several poorly defined aspects, which have significantly delayed the availability of fully satisfactory drugs capable of achieving complete recovery.
The indication for radical surgery is not clearly defined, but this kind of treatment should only be instituted when conservative methods fail or when severe bone and soft-tissue necrosis prevails.
Doble injerto microvascularizado de peroné para reconstrucción bilateral mandibular por osteorradionecrosis · 2010 · DOISUMMARY: Thorough reporting of every case of ONJ is important to help advance the understanding of this poorly understood condition.
Most-cited papers in Bone health and treatments
- American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update · Journal of Oral and Maxillofacial Surgery · 2022 · 995 citations
- Bone cancer pain · Annals of the New York Academy of Sciences · 2010 · 230 citations
- Italian position paper ( <scp>SIPMO‐SICMF</scp> ) on medication‐related osteonecrosis of the jaw ( <scp>MRONJ</scp> ) · Oral Diseases · 2024 · 108 citations
- Learning from experience. Proposal of a refined definition and staging system for bisphosphonate‐related osteonecrosis of the jaw (BRONJ) · Oral Diseases · 2012 · 103 citations
- Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment · Clinical Oral Implants Research · 2012 · 98 citations
- Updates on bisphosphonates and potential pathobiology of bisphosphonate‐induced jaw osteonecrosis · Oral Diseases · 2007 · 91 citations
- Bisphosphonates‐related osteonecrosis of the jaws: a concise review of the literature and a report of a single‐centre experience with 151 patients · Journal of Oral Pathology and Medicine · 2011 · 90 citations
- Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four‐case report · Journal of Oral Pathology and Medicine · 2005 · 77 citations
- A review of the clinical implications of bisphosphonates in dentistry · Australian Dental Journal · 2010 · 59 citations
- Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis · Dentomaxillofacial Radiology · 2011 · 58 citations
Most recent work
- Involucrum Formation Leading to Healing in Stage 3 Medication‐Related Osteonecrosis of the Jaws · Special Care in Dentistry · 2026
- 1,8-Naphthalimide-Based Fluorescent Bisphosphonates: Molecular Design, Spectral-Luminescent Properties, and Osteotropic Targeted Delivery Systems · Russian Journal of Bioorganic Chemistry · 2026
- A case of medication-related osteonecrosis of the jaw originating from peri-implantitis that responded to conservative treatment with hyperbaric oxygen therapy · Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology · 2026
- Letter to the Editor: Magnetic resonance fingerprinting in the quantitative assessment of bone metastases—technical developments and clinical future · European Radiology · 2026
- Skeletal Metastatic Mimicry in Ovarian Cancer: A Case Report on the Diagnostic Challenges of Osteopetrosis and Metabolic Bone Disease · Bangladesh Journal of Nuclear Medicine · 2026
- Synergistic application of concentrated growth factor and bone perforation technique in bisphosphonate-related-osteonecrosis of the jaw · BMC Oral Health · 2026
- Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directions · Frontiers in Oncology · 2026
- EVALUATION OF BONE METASTASES DETECTION USING BONE SCINTIGRAPHY IN PROSTATE CANCER PATIENTS · Zenodo (CERN European Organization for Nuclear Research) · 2026
- Paget's Disease of the Spine as a Catalyst for Osteosarcoma: A Narrative Review · Cureus · 2026
- Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer · NEJM Evidence · 2026
Find a gap in your own Bone health and treatments sub-topic
This page shows what the Bone health and treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →